反激动剂
帕金森病
受体
孤儿受体
配体(生物化学)
细胞生物学
痛苦
药理学
G蛋白偶联受体
神经科学
信号转导
生物
化学
生物化学
内科学
医学
疾病
敌手
基因
政治
转录因子
政治学
法学
作者
Mahta Barekatain,Linda C. Johansson,Jordy Homing Lam,Hao Chang,Anastasiia Sadybekov,Gye Won Han,Joseph Russo,Joshua Bliesath,Nicola Brice,Mark Carlton,Kumar Singh Saikatendu,Hongyang Sun,Sean T. Murphy,Holger Monenschein,Hans H. Schiffer,Petr Popov,Corinne A. Lutomski,Carol V. Robinson,Zhi‐Jie Liu,Tian Hua
出处
期刊:Science Signaling
[American Association for the Advancement of Science]
日期:2024-12-03
卷期号:17 (865)
被引量:2
标识
DOI:10.1126/scisignal.ado8741
摘要
GPR6 is an orphan G protein–coupled receptor with high constitutive activity found in D2-type dopamine receptor–expressing medium spiny neurons of the striatopallidal pathway, which is aberrantly hyperactivated in Parkinson’s disease. Here, we solved crystal structures of GPR6 without the addition of a ligand (a pseudo-apo state) and in complex with two inverse agonists, including CVN424, which improved motor symptoms in patients with Parkinson’s disease in clinical trials. In addition, we obtained a cryo–electron microscopy structure of the signaling complex between GPR6 and its cognate G s heterotrimer. The pseudo-apo structure revealed a strong density in the orthosteric pocket of GPR6 corresponding to a lipid-like endogenous ligand. A combination of site-directed mutagenesis, native mass spectrometry, and computer modeling suggested potential mechanisms for high constitutive activity and inverse agonism in GPR6 and identified a series of lipids and ions bound to the receptor. The structures and results obtained in this study could guide the rational design of drugs that modulate GPR6 signaling.
科研通智能强力驱动
Strongly Powered by AbleSci AI